Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Personalized oral dosing plan with specific timing, frequency, and duration tailored to your digestive concerns and therapeutic goals
This improved tolerance makes it suitable for longer-term use
The SURPASS-PEDS trial demonstrated safety and efficacy in this younger population
Semaglutide has been associated with early worsening of diabetic retinopathy in clinical trials, particularly in patients with pre-existing retinopathy and rapid improvement in glycaemic control
US$ 26.79
US$ 25.25
US$ 25.43
US$ 20.83
